Cancer recurrence fears 'overlooked'

February 24, 2009

(PhysOrg.com) -- The anxiety of cancer returning is often overlooked by both patients and medics, according to leading experts in the disease.

Health experts from around the world will gather in Scotland this week to examine cancer patients - fears of recurrence following treatment, and outline new methods to contain unrealistic fears.

Organised by cancer specialists at the University of St Andrews, the international group will come together to improve supplementary psychological care during the recovery process.

The experts hope to gain new understanding into the ways in which patients attempt to cope with the possibility of a recurrence and the psychological effects of this uncertainty.

Organiser Gerry Humphris, Professor of Health Psychology at the University of St Andrews, said, "The psychological after-effects of a cancer diagnosis and the burden of life saving medical treatments has received close attention by social scientists and medical teams alike; however the anxiety of the cancer returning is one that is often over looked in the clinics as both patients and clinicians concentrate on irradiating the disease."

The theme of the colloquium, which will bring together leading researchers from Europe, America, Australia and New Zealand, is ' Fear of Recurrence'.

Professor Humphris continued, "Recently, international experts have agreed that the study of this neglected psychological construct is paramount to understanding patients' longer term recovery and mental well being.

"The study of fears of recurrence is long overdue as many patients have volunteered their concerns over the years. It is hoped that this colloquium will enable a strong focus to be applied to defining, assessing, describing associated clinical phenomena and outlining new methods to contain unrealistic fears."

Provided by University of St Andrews

Explore further: Team aims to help patients with cancer make complex care decisions

Related Stories

Team aims to help patients with cancer make complex care decisions

November 22, 2017
Researchers at the University of Virginia Cancer Center are developing a tool to help patients with prostate cancer better understand the potential risks and rewards of their treatment options. And that tool could ultimately ...

More care is needed for cancer supportive care

November 20, 2017
The relentless efforts devoted to improving prevention, early detection, and treatment have resulted in more and more cancer survivors worldwide. In fact, there is a decrease in overall cancer mortality rate of about 1% per ...

Breast cancer patients forego post-surgery treatment due to mistrust, study suggests

November 1, 2017
Nearly one-third of women with breast cancer went against their doctor's advice and chose not to begin or complete the recommended adjuvant anti-cancer therapy to kill residual tumor cells following surgery, according to ...

Diverse drug-resistant cancer cells share a hidden weakness

November 6, 2017
UC San Francisco researchers have discovered a gene vulnerability that could let oncologists wipe out drug-resistant cancers across many different cancer types. The findings, published in Nature on November 1, 2017, suggest ...

Fighting cancer with cancer: 3-D cultured cells could drive precision therapy

November 8, 2017
Honeycomb-like arrays of tiny, lab-grown cancers could one day help doctors zero in on individualized treatments for ovarian cancer, an unpredictable disease that kills more than 14,000 women each year in the United States ...

New talking therapy could help cancer survivors cope after treatment

November 16, 2017
Even though cancer survivors may be in good physical health or in long-term remission, the impact of cancer and its treatment can be very difficult. The researchers hope that the new therapy will transform aftercare for those ...

Recommended for you

Researchers unravel novel mechanism by which tumors grow resistant to radiotherapy

November 23, 2017
A Ludwig Cancer Research study has uncovered a key mechanism by which tumors develop resistance to radiation therapy and shown how such resistance might be overcome with drugs that are currently under development. The discovery ...

African Americans face highest risk for multiple myeloma yet underrepresented in research

November 23, 2017
Though African-American men are three times more likely to be diagnosed with multiple myeloma, a type of blood cancer, most scientific research on the disease has been based on people of European descent, according to a study ...

Encouraging oxygen's assault on iron may offer new way to kill lung cancer cells

November 22, 2017
Blocking the action of a key protein frees oxygen to damage iron-dependent proteins in lung and breast cancer cells, slowing their growth and making them easier to kill. This is the implication of a study led by researchers ...

One-size treatment for blood cancer probably doesn't fit all, researchers say

November 22, 2017
Though African-American men are three times more likely to be diagnosed with a blood cancer called multiple myeloma, most scientific research on the disease has been based on people of European descent, according to a study ...

One in four U.S. seniors with cancer has had it before

November 22, 2017
(HealthDay)—For a quarter of American seniors, a cancer diagnosis signals the return of an old foe, new research shows.

Combination immunotherapy targets cancer resistance

November 22, 2017
Cancer immunotherapy drugs have had notable but limited success because in many cases, tumors develop resistance to treatment. But researchers at Yale and Stanford have identified an experimental antibody that overcomes this ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.